CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

NCT02424968 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
B-Cell Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Hodgkin Lymphoma
Myelodysplastic Syndrome
Myeloproliferative Neoplasm
T-Cell Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclosporine
DRUG: Mycophenolate Mofetil
PROCEDURE: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant
BIOLOGICAL: Allogeneic Cluster of Differentiation 8 (CD8)+ Memory T-cells
RADIATION: Total Nodal Irradiation

Sponsor

Robert Lowsky

Collaborators

[object Object]